References
- Lee JM. Dongeuisusebowon. Seoul:Yeogang Publishing Co. 1992:243-271.(Korean)
- Lee JM. Dongeuisusebowon. Seoul:Shinil Publishing Co. 1964:70.(Korean)
- Kim KY. The approach of Sasang constitutional medicine in incurable disease and immunity. J Sasang Constitut Med. 1995;7(2):113-128.(Korean)
- Choi AY, Ha JH, Lee JH, Jang WS, Goo DM. A clinical study on strabismus patient of abducence nerve paralysis in Soyangin improved with Yangkyuksanhwa-tang. J Sasang Constitut Med. 2008;20 (3):176-183.(Korean)
- Lo HS, Lee SM, Bae YC, Park HS, Lee JS, Song SG, et al. The Effect of Yangkyuksanhwa-tang on cytokine production in the patients with cerebral infarction J Sasang Constitut Med. 2004;16(1):120-129. (Korean)
- Choi DJ, Ryu SH, Jung WS, Moon SK, Cho KH, Kim YS. The clinical efficacy of Yangkyuksanwha-tang on acute stroke. J Korean Oriental Med. 2004;25(1):111-116.(Korean)
- Kim SJ, Kim MS, Seo BI, Gu DM, Seo HY, An HD. One case report of urinary and bowel dysfunction treated with Yangkyuksanwha-tang in cerebrovascular accident patient. Kor J Herbology. 2003;18(3):1-8.(Korean)
- Jung SI, Kim JW. Clinical study about the diabetes mellitus patients administration of Yangkyuksanwhatang. Korea J Oriental Physiology & Pathology. 2002;16(6):1308-1313. (Korean)
- Cho SW. Effects of Yangkyuksanhawtang on the allergic contact dermatitis. Korean Journal of Korean Medical Institute of Dermatology & Aesthetics. 2005;1(1):16-40. (Korean)
- Soh YJ. Protective effect of Yangguksanwha-tang metabolized by liver homogenate on hypoxia-reperfusion induced PC12 cell damage. Yakhak Hoeji. 2005;49(1):97-102. (Korean)
- Son SK, Shin MG, Song IB. Effects of Yanggyuksanhwatang on cerebral blood flow and Ischemic brain damage in rats. J Sasang Constitut Med. 2001;13(2):165-176. (Korean)
- Boo IG, Kim YS. Immunohistochemical study of Yanggyuksanhwa-tang on focal cerebral ischemia of diabetic rats. Korea J Oriental Physiology & Pathology. 2007;21(3):741-747.(Korean),
- Yun BH, Park SS. Yangkyuksanhwa-tang effected to atopic dermatitis. J Sasang Constitut Med. 2004;16(2):84-98.(Korean)
- Kim EJ, Kim YS. Effects of Yanggyuksanhwa-tang on global cerebral ischemia of diabetic rats induced by streptozotocin. Korea J Oriental Physiology & Pathology. 2007;21(2):474-478.(Korean)
- Lee SY, Choi AY, Ha JH, Lee JH, Kim PJ, Goo DM. An experimental study on the anti-stress effect by Soyangin Hyeongbangdojeok-san and Yanggyeoksanhwa-tang. J Sasang Constitut Med. 2008;20(3): 151-163.(Korean)
-
Liew FY, Lia Y, Millot S. Tumor necrosis factor synergizes with IFN-
$\gamma$ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol. 1990;145:4306-4310. - Thornberry NA, Molineaux SX. Interleukin-1 beta converting enzyme: a novel cystein protease required for IL-1 beta production and implicated in progammed cell death. Protein Sci. 2005;4:3-12.
- Burger D, Dayer JM, Palmer G, Gabay C. Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract Clin Rheumatol. 2006;20(5):879-896. https://doi.org/10.1016/j.berh.2006.06.004
- Sung CS, Wong CS. Cellular mechanisms of neuroinflammatory pain: the role of interleukin-1beta. Act Anaesthsiol Taiwan. 2007;45(2):103-109.
- Weiss L. Cell and tissue biology 6th ed. Uraban & Schwarzenbeg. Baltimore. 1988;481-538.
- Zalys R, Zagon IS, Bonneau RH, Lang CM, McLaughlin PJ. In vivo effect of chronic treatment with (MET5)-en-kephain on hematological values and natural killer cell activity in athymic mice. Life Sci. 2000;66:829-834. https://doi.org/10.1016/S0024-3205(99)00655-4
- James GL. Methods in Immunotoxicology. John Wiley-Liss, Inc, San Diego. 1995;2-15.